IRIS
BAGALONI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.806
EU - Europa 919
AS - Asia 664
SA - Sud America 83
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 18
OC - Oceania 18
Totale 3.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.754
CN - Cina 263
SG - Singapore 219
IT - Italia 216
GB - Regno Unito 151
RU - Federazione Russa 132
UA - Ucraina 106
SE - Svezia 90
BR - Brasile 64
FR - Francia 59
DE - Germania 56
TR - Turchia 56
VN - Vietnam 47
FI - Finlandia 32
IE - Irlanda 27
CA - Canada 23
AU - Australia 17
HK - Hong Kong 15
MX - Messico 15
IN - India 13
ES - Italia 11
AR - Argentina 8
JP - Giappone 8
NL - Olanda 8
PL - Polonia 8
ZA - Sudafrica 8
IQ - Iraq 6
KR - Corea 6
BD - Bangladesh 5
BE - Belgio 4
EG - Egitto 4
IR - Iran 4
LT - Lituania 4
AT - Austria 3
EC - Ecuador 3
ID - Indonesia 3
LK - Sri Lanka 3
MA - Marocco 3
BH - Bahrain 2
CR - Costa Rica 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
HN - Honduras 2
MD - Moldavia 2
PK - Pakistan 2
PR - Porto Rico 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HT - Haiti 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.511
Salva come PNG Salva come JPEG
Città #
Ashburn 255
Fairfield 173
Woodbridge 141
Singapore 135
Southend 109
Houston 94
Cambridge 83
Ann Arbor 82
Seattle 77
Jacksonville 75
San Jose 73
Wilmington 63
Beijing 52
Chandler 46
New York 44
Dallas 37
Nanjing 35
Boardman 30
Urbino 30
Izmir 29
Council Bluffs 26
Los Angeles 25
Dublin 22
Ho Chi Minh City 18
Lauterbourg 17
Santa Clara 17
Helsinki 16
Bremen 15
Düsseldorf 15
Hong Kong 15
Princeton 15
Hebei 14
Sydney 14
Dearborn 12
Moscow 12
Chicago 11
Milan 11
San Francisco 11
Tianjin 11
Brooklyn 10
Rome 10
San Diego 10
Shenyang 10
São Paulo 10
North Bergen 9
Changsha 8
Frankfurt am Main 8
Guangzhou 8
Hanoi 8
Istanbul 8
London 8
Redwood City 8
Vittuone 8
Boston 7
Jiaxing 7
Jinan 7
Johannesburg 7
Kocaeli 7
Pontedera 7
Tokyo 7
Atlanta 6
Bisceglie 6
Denver 6
Nanchang 6
Nuremberg 6
Toronto 6
Cagliari 5
Montreal 5
Poplar 5
Rimini 5
The Dalles 5
Ankara 4
Brussels 4
Kunming 4
Lappeenranta 4
Leawood 4
Menlo Park 4
Mexico City 4
Newark 4
Portland 4
Querétaro 4
Redondo Beach 4
San Mateo 4
Seongnam 4
Turku 4
Warsaw 4
Augusta 3
Buffalo 3
Cairo 3
Canberra 3
Colombo 3
Columbus 3
Des Moines 3
Elk Grove Village 3
Gurgaon 3
Lecce 3
Ningbo 3
Norfolk 3
Quito 3
Shanghai 3
Totale 2.295
Salva come PNG Salva come JPEG
Nome #
XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT 318
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells. 309
DNA demethylating antineoplastic strategies: a comparative point of view. 272
Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma. 270
Malten, a new synthetic molecule showing in vitro antiproliferative activity against tumor cells and induction of complex DNA structural alterations. 229
Sex-Related Differences in Impact On Safety Of Pharmacogenetic Profile For Colon Cancer Patients Treated With FOLFOX-4 or XELOX Adjuvant Chemotherapy 226
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with Ramucirumab-Paclitaxel or standard chemotherapy 225
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomized, phase III adjuvant TOSCA trial in high-risk colon cancer patients. 199
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib 177
Patients treated with FOLFOX-4 or XELOX chemotherapy with high-risk stage II and III colon cancer (TOSCA trial): a different impact of pharmacogenetic profile on toxicity in women and men 175
A pharmacogenetic study for clinical outcomes of high-risk stage II and stage III colon cancer patients Treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy 161
TP53 mutation analysis in gastric cancer and clinical outcomes of patients with metastatic disease treated with antiangiogenic or standard chemotherapy regimens 157
Glycolytic competence in gastric adenocarcinomas negatively impacts on survival outcomes of patients treated with salvage paclitaxel-ramucirumab. 154
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma 154
Warburg effect and tp53 mutational status in gastric cancer patients under ramucirumab-based therapy 152
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES MAY AFFECT THE LOSS OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS 146
POLYMORPHISMS IN MULTIDRUG RESISTANCE TRANSPORTER GENES AFFECT THE DURATION OF MOLECULAR RESPONSE TO NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS 130
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy 120
Totale 3.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.305
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022220 0 0 0 63 9 14 9 32 15 10 22 46
2022/2023218 43 11 11 16 23 39 4 10 39 4 9 9
2023/2024147 13 10 4 11 12 44 4 8 0 20 4 17
2024/2025402 18 10 74 23 18 25 93 15 15 45 54 12
2025/2026913 120 70 89 192 84 83 72 31 64 65 35 8
2026/2027168 23 13 60 72 0 0 0 0 0 0 0 0
Totale 3.574